Carl Zeiss Medic experiences ‘solid growth’
Carl Zeiss Meditec AG on 16 May announced it experienced solid growth for the six months ended 30 March, partly due to the strong performance of its microsurgery strategic business unit.
The company reported despite negative currency effects, revenue grew to €613.7 million, an increase of 4.5 per cent from year ago, or 9.5 per cent adjusted for currency effects.
Adjusted earnings before interest and taxes (EBIT) amounted to around €90 million versus €89.1 million the prior year.
The adjusted EBIT margin was 14.7 per cent compared with 15.2 per cent a year ago.
Lens sales boost Hoya’s 4Q 2017 revenue
Lens sales boosted total sales for the Hoya Group during the fourth quarter ended 31 March, rising 7.6 per cent year on year, reaching 135,923 million yen, and 7 per cent on a constant currency basis.
During the fourth quarter, Hoya’s Life Care unit posted 91.9 million yen in sales, a 10 per cent increase over year ago, and an 8 per cent increase on a constant currency basis.
Lens sales rose 12 per cent, or 2 per cent like-for-like, compared with fourth quarter 2016. Contact lens sales rose 5 per cent versus a year ago; IOL sales rose 14 per cent versus a year ago.
Despite recording 5,615 million yen in impairment losses on fixed assets, profit growth stemming from higher revenues, productivity improvements, expense reductions and other measures, Hoya generated a quarterly profit before tax of 26,150 million yen and profit of 19,535 million yen, year-on-year increases of 7.1 per cent and 2.0 per cent, respectively.